Viralytics Ltd. (VLA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Viralytics Ltd. (VLA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Viralytics Ltd. (VLA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Viralytics Ltd. (VLA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
24 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Viralytics Limited (Viralytics), formerly Psiron Limited is a biotechnology company that develops oncology products for the pharmaceutical industry. It develops and markets oncolytic immunotherapies for the treatment of different types of cancers. The companys lead product candidate CAVATAKTM is a proprietary formulation for the common cold Coxsackievirus Type A21 (CVA21), is being evaluated in phase 1 and 2 clinical trials. CAVATAKTM is an oncolytic common cold virus that has demonstrated anti-tumor activity, by following a process called lysis. It gets attaches itself to a protein found on surface of cancer cells, gets inserted, replicates and burst the cancer cells apart.

Viralytics Ltd. (VLA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the com

  
Source:
Document ID
GDPH4174D
Country
Industry
Ticker
VLA=AU
Company
Format:
PDF Adobe Acrobat
Buy Now

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Viralytics Ltd. (VLA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Viralytics-Ltd-VLA-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-10112>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Viralytics Ltd. (VLA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Viralytics-Ltd-VLA-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-10112>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research